Rafferty Asset Management, LLC
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1389426
New York, NY
Position in REGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$24,027,490
+$1,165,846 QoQ
Shares Held
38,534
+30.2% QoQ
Ownership
0.037%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#191
of 1,322 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Rafferty Asset Management, LLC holds $331,711,589 across 163 Biotechnology names. REGN ranks #2 (7.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
65,798 | $32,683,840 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
38,534 | $24,027,490 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
55,332 | $16,656,591 | |
| 4 | MRNA |
Moderna, Inc.
|
111,906 | $7,836,777 | |
| 5 | INCY |
Incyte Corp
|
44,663 | $5,062,997 | |
| 6 | APGE |
Apogee Therapeutics, Inc.
|
33,369 | $4,429,067 | |
| 7 | ORKA |
Oruka Therapeutics, Inc.
|
43,110 | $4,102,778 | |
| 8 | KYMR |
Kymera Therapeutics, Inc.
|
35,287 | $4,046,360 |
All Filings in REGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $24,027,490 | 38,534 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $22,861,644 | 29,589 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $27,261,676 | 35,319 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $26,129,811 | 46,472 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $27,629,700 | 52,628 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $28,351,349 | 44,702 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $33,912,606 | 47,608 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $37,528,216 | 35,699 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $43,320,303 | 41,217 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $32,023,967 | 33,272 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $30,016,439 | 34,176 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $26,379,982 | 32,055 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $22,018,939 | 30,644 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $21,094,733 | 25,673 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $18,785,435 | 26,037 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $17,078,465 | 24,792 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $12,014,717 | 20,325 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $14,821,869 | 21,222 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $11,421,670 | 18,086 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $8,835,022 | 14,599 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $7,782,696 | 13,934 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $7,865,952 | 16,625 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $5,391,024 | 11,159 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $5,968,374 | 10,662 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $5,584,162 | 8,954 | Shares | Sole | 2020-08-07 | |
| 2020-03-31 | $4,014,232 | 8,221 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||